Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…
Medical - Specialties
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Delcath Systems, Inc. (DCTH) to it's peer group.
Peer Group
LIVN TMDX ITGR IRMD CVRX CLPT TELA TMCI NPCE OSA KIDS RCEL SGHT OFIX SRDX TBIO LUNG
Compare Together
Loading...